These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 31855154
1. Intravenous ferric carboxymaltose is effective and safe in patients with inflammatory rheumatic diseases. Salvadori U, Vittadello F, Al-Khaffaf A, Maier A, Cappelletto PC, Daves M, Raffeiner B. Blood Transfus; 2020 May; 18(3):176-181. PubMed ID: 31855154 [Abstract] [Full Text] [Related]
2. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Lyseng-Williamson KA, Keating GM. Drugs; 2009 May; 69(6):739-56. PubMed ID: 19405553 [Abstract] [Full Text] [Related]
3. Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease. Beigel F, Löhr B, Laubender RP, Tillack C, Schnitzler F, Breiteneicher S, Weidinger M, Göke B, Seiderer J, Ochsenkühn T, Brand S. Digestion; 2012 May; 85(1):47-54. PubMed ID: 22179489 [Abstract] [Full Text] [Related]
4. Role of Intravenous Ferric Carboxy-maltose in Pregnant Women with Iron Deficiency Anaemia. Mishra V, Gandhi K, Roy P, Hokabaj S, Shah KN. J Nepal Health Res Counc; 2017 Sep 08; 15(2):96-99. PubMed ID: 29016575 [Abstract] [Full Text] [Related]
6. Real-world efficacy and safety of intravenous ferric carboxymaltose for the management of iron deficiency anaemia in Malaysia: A single centre cohort study. Kamarul HNB. Med J Malaysia; 2024 Sep 08; 79(5):517-524. PubMed ID: 39352152 [Abstract] [Full Text] [Related]
7. Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial. Howaldt S, Domènech E, Martinez N, Schmidt C, Bokemeyer B. Inflamm Bowel Dis; 2022 Mar 02; 28(3):373-384. PubMed ID: 33988236 [Abstract] [Full Text] [Related]
12. Intravenous ferric carboxymaltose for anaemia in pregnancy. Froessler B, Collingwood J, Hodyl NA, Dekker G. BMC Pregnancy Childbirth; 2014 Mar 25; 14():115. PubMed ID: 24667031 [Abstract] [Full Text] [Related]
13. Safety and efficacy of parenteral iron in children with inflammatory bowel disease. Papadopoulos M, Patel D, Korologou-Linden R, Goto E, Soondrum K, Fell JME, Epstein J. Br J Clin Pharmacol; 2018 Apr 25; 84(4):694-699. PubMed ID: 29266387 [Abstract] [Full Text] [Related]
16. Ferric Carboxymaltose: A Review in Iron Deficiency. Scott LJ. Drugs; 2018 Mar 25; 78(4):479-493. PubMed ID: 29532438 [Abstract] [Full Text] [Related]
19. Randomized Controlled Trial of Intravenous Ferric Carboxymaltose vs Oral Iron to Treat Iron Deficiency Anemia After Variceal Bleed in Patients With Cirrhosis. Tabish M, Agarwal S, Gopi S, Rana R, Ahmed S, Gunjan D, Sharma S, Saraya A. Am J Gastroenterol; 2024 Oct 01; 119(10):2061-2069. PubMed ID: 38517084 [Abstract] [Full Text] [Related]
20. Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. Wolf M, Rubin J, Achebe M, Econs MJ, Peacock M, Imel EA, Thomsen LL, Carpenter TO, Weber T, Brandenburg V, Zoller H. JAMA; 2020 Feb 04; 323(5):432-443. PubMed ID: 32016310 [Abstract] [Full Text] [Related] Page: [Next] [New Search]